$FBIZ

First Business Financial Services (NASDAQ:FBIZ) Q4 2025 Earnings: EPS Beats, Revenue Misses, Dividend Raised 17%

First Business Financial Services (NASDAQ:FBIZ) reported mixed Q4 2025 results, with diluted EPS of $1.58 surpassing analyst estimates of $1.42, while operating revenue of $42.2 million missed expectations of $43.9 million. The company announced a 17% increase in its quarterly cash dividend to $0.34 per share, marking its 14th consecutive annual dividend increase. Despite a revenue miss and an increase in non-performing assets, the stock's market reaction was muted as investors balanced positive EPS and dividend news.

Original reporting
Chartmill · Mill Chart
Published Jan 30, 2026, 3:32 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jan 30, 2026, 4:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
First Business Financial Services (NASDAQ:FBIZ) Q4 2025 Earnings: EPS Beats, Revenue Misses, Dividend Raised 17% — source image
Decision brief

The 30-second read

$FBIZNeutralMed
01

Why it matters

While EPS beat and dividend hike are positive, revenue miss and asset quality issues warrant caution. The market's muted response indicates investor prudence.

02

Market read

The news is moderately relevant for investors in regional banks, with potential implications for similar institutions, but limited impact on broader markets.

03

What to watch

Potential macroeconomic headwinds and interest rate environment may influence future earnings and asset quality.

Timing: short-term (next 1-2 weeks)

Background

First Business Financial Services operates in the regional banking sector, with a focus on small to mid-sized businesses. The company’s Q4 2025 results reflect broader industry challenges amid economic uncertainties.

Company-level read

Ticker impact

$FBIZNeutralMedium confidence
Context

The news pertains directly to First Business Financial Services (NASDAQ:FBIZ), highlighting its Q4 2025 earnings, dividend increase, and revenue performance.

Expected impact

Likely minimal short-term price movement; potential slight upward bias due to dividend increase, but revenue miss and asset quality concerns may temper gains.

Evidence & confidence

The mixed earnings and dividend increase suggest a cautious but somewhat optimistic outlook. The muted market reaction indicates limited immediate impact, but ongoing asset quality issues could influence future performance.

Market effects

The financial sector may experience slight positive bias due to dividend hike, but asset quality concerns could weigh on sector sentiment.

Limited regional impact; primarily relevant to US regional banks and financial institutions.

Negligible

Counterpoint

The revenue miss and rising non-performing assets could signal underlying financial stress, suggesting potential downside in the medium term.

Key entities

  • First Business Financial Services

    A regional bank providing financial services to small and mid-sized businesses.

Related articles

$FBIZMedAI 8/10

FBIZ Q2 2026 Earnings Call Transcript

First Business Financial Services (FBIZ) reported Q2 2026 diluted EPS of $1.84, including $0.14 per share from one-time tax and SBA severance items. Pretax preprovision earnings were $19.8 million, up 15.1% QoQ. NIM rose to 3.78% and guidance for 2026 is 3.60% to 3.65%. The company exited national SBA 7(a) lending and cited capital strength (CET1 9.54%).

$FBIZMed

First Business Financial Services: Q2 Earnings Snapshot

MADISON, Wis. (AP) — MADISON, Wis. (AP) — First Business Financial Services Inc. (FBIZ) on Thursday reported second-quarter net income of $15.6 million. The bank, based in Madison, Wisconsin, said it had earnings of $1.84 per share. Earnings, adjusted for pretax gains, came to $1.70 per share. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.54 per share.

$FBIZMed

FIRST BUSINESS FINANCIAL SERVICES, INC. (FBIZ): Results of Operations and Financial Condition

FIRST BUSINESS FINANCIAL SERVICES, INC. (FBIZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FIRST BUSINESS BANK ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS -- Sustained balance sheet growth and disciplined operating efficiency drive exceptional earnings and tangible book value growth -- MADISON, Wis., July 30, 2026 (BUSINESS WIRE) -- First Business Fina

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.